Clinical Trials

NCT03656835 | ACTIVE_NOT_RECRUITING | NA
73 participants

Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2018-09-26
Completion:
2024-11-20
Conditions
  • Diffuse Large B-Cell Lymphoma
  • Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • High Grade B-Cell Lymphoma
Interventions
  • PROCEDURE
No Results Yet
NCT03419234 | ACTIVE_NOT_RECRUITING | PHASE2
223 participants

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2018-04-26
Completion:
2024-01-08
Conditions
  • Castration Levels of Testosterone
  • Castration-Resistant Prostate Carcinoma
  • Metastatic Prostate Carcinoma in the Soft Tissue
  • Prostate Carcinoma Metastatic in the Bone
  • Stage IV Prostate Adenocarcinoma AJCC v7
Interventions
  • DRUG
NCT03101410 | COMPLETED | NA
51 participants

Gluten Sensibility in Elite Athletes

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2017-04-01
Completion:
2018-03-21
Conditions
  • Intestinal Diseases
  • Gluten-sensitive
Interventions
  • BEHAVIORAL
No Results Yet
NCT02861417 | ACTIVE_NOT_RECRUITING | PHASE2
204 participants

Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2016-08-05
Completion:
2028-08-31
Conditions
  • Hematopoietic and Lymphoid Cell Neoplasm
  • High Risk Acute Myeloid Leukemia
  • High Risk Myelodysplastic Syndrome
  • Lymphoproliferative Disorder
  • Myelodysplastic Syndrome
  • Myelodysplastic/Myeloproliferative Neoplasm
  • Recurrent Acute Lymphoblastic Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Recurrent High Risk Myelodysplastic Syndrome
  • Recurrent Hodgkin Lymphoma
  • Recurrent Myelodysplastic Syndrome
  • Recurrent Non-Hodgkin Lymphoma
  • Recurrent Plasma Cell Myeloma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
No Results Yet
NCT02311933 | ACTIVE_NOT_RECRUITING | PHASE2
81 participants

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2015-05-28
Completion:
2020-11-06
Conditions
  • Recurrent Breast Carcinoma
  • Stage III Breast Cancer AJCC v7
  • Stage IIIA Breast Cancer AJCC v7
  • Stage IIIB Breast Cancer AJCC v7
  • Stage IIIC Breast Cancer AJCC v7
  • Stage IV Breast Cancer AJCC v6 and v7
Interventions
  • DRUG
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page